Baidu
map

进展

订阅

MedSci主页 / 所有栏目 / 进展

Med Sci Monit：阿托伐他汀和叶酸对慢性心力衰竭高同型半胱氨酸血症患者心功能和心室重构的协同作用

2019-08-28 sunshine 译 MedSci原创

关注

背景目前在慢性心力衰竭（CHF）的病理生理学理解和治疗方面不断取得进展。同时，高同型半胱氨酸血症（HHcy）与CHF患者的左心室功能受损和临床分级有关。阿托伐他汀治疗可以降低晚期CHF患者心源性猝死的发生率。叶酸可以增强血管疾病状态下的内皮功能。本研究旨在探讨阿托伐他汀和叶酸联合对CHF患者HHcy心功能和心室重构的影响。材料与方法伴HHcy的老年CHF患者分为四组：常规，常规+阿托伐他汀，常规+

背景
目前在慢性心力衰竭（CHF）的病理生理学理解和治疗方面不断取得进展。同时，高同型半胱氨酸血症（HHcy）与CHF患者的左心室功能受损和临床分级有关。阿托伐他汀治疗可以降低晚期CHF患者心源性猝死的发生率。叶酸可以增强血管疾病状态下的内皮功能。本研究旨在探讨阿托伐他汀和叶酸联合对CHF患者HHcy心功能和心室重构的影响。

材料与方法
伴HHcy的老年CHF患者分为四组：常规，常规+阿托伐他汀，常规+叶酸和常规+阿托伐他汀+叶酸组。使用酶循环方法检测血清同型半胱氨酸（Hcy）的水平，通过ELISA检测N末端脑钠尿肽（NT-proBNP）的水平。评估心功能指标和左心室舒张早期峰值流速/心房收缩峰值流速（E/A）比值。进行六分钟步行测试以测量六分钟步行距离（6MWD）。

结果
6MWD增加，血清Hcy和NT-proBNP水平下降，心功能较治疗前有所改善，这在常规+阿托伐他汀+叶酸组中最为明显，其次是常规+阿托伐他汀组，然后是常规+叶酸组，最后是常规组。

结论
结果表明，阿托伐他汀和叶酸联合应用可改善伴HHcy的老年CHF患者的心功能，抑制心室重构。

原始出处：

Peng Y, Ou BQ, et al., Synergistic Effect of Atorvastatin and Folic Acid on Cardiac Function and Ventricular Remodeling in Chronic Heart Failure Patients with Hyperhomocysteinemia. Med Sci Monit. 2018 Jun 4;24:3744-3751. doi: 10.12659/MSM.906893.

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1251806, encodeId=110e12518061e, content=<a href='/topic/show?id=ac5d5351ea8' target=_blank style='color:#2F92EE;'>#慢性心力衰竭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53517, encryptionId=ac5d5351ea8, topicName=慢性心力衰竭)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297775, encodeId=e3e0129e77537, content=<a href='/topic/show?id=33c1509e135' target=_blank style='color:#2F92EE;'>#心室重构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50971, encryptionId=33c1509e135, topicName=心室重构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465688, encodeId=dd7c14656881d, content=<a href='/topic/show?id=5f5f508933f' target=_blank style='color:#2F92EE;'>#心功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50893, encryptionId=5f5f508933f, topicName=心功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6df96750284, createdName=caobinglei8081, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609964, encodeId=3c8d160996471, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=)]
    2019-08-30 bioon1

    #慢性心力衰竭#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1251806, encodeId=110e12518061e, content=<a href='/topic/show?id=ac5d5351ea8' target=_blank style='color:#2F92EE;'>#慢性心力衰竭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53517, encryptionId=ac5d5351ea8, topicName=慢性心力衰竭)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297775, encodeId=e3e0129e77537, content=<a href='/topic/show?id=33c1509e135' target=_blank style='color:#2F92EE;'>#心室重构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50971, encryptionId=33c1509e135, topicName=心室重构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465688, encodeId=dd7c14656881d, content=<a href='/topic/show?id=5f5f508933f' target=_blank style='color:#2F92EE;'>#心功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50893, encryptionId=5f5f508933f, topicName=心功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6df96750284, createdName=caobinglei8081, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609964, encodeId=3c8d160996471, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=)]
    2019-08-30 fanweitanzhen

    #心室重构#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1251806, encodeId=110e12518061e, content=<a href='/topic/show?id=ac5d5351ea8' target=_blank style='color:#2F92EE;'>#慢性心力衰竭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53517, encryptionId=ac5d5351ea8, topicName=慢性心力衰竭)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297775, encodeId=e3e0129e77537, content=<a href='/topic/show?id=33c1509e135' target=_blank style='color:#2F92EE;'>#心室重构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50971, encryptionId=33c1509e135, topicName=心室重构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465688, encodeId=dd7c14656881d, content=<a href='/topic/show?id=5f5f508933f' target=_blank style='color:#2F92EE;'>#心功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50893, encryptionId=5f5f508933f, topicName=心功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6df96750284, createdName=caobinglei8081, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609964, encodeId=3c8d160996471, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=)]
    2019-08-30 caobinglei8081

    #心功能#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1251806, encodeId=110e12518061e, content=<a href='/topic/show?id=ac5d5351ea8' target=_blank style='color:#2F92EE;'>#慢性心力衰竭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=53517, encryptionId=ac5d5351ea8, topicName=慢性心力衰竭)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=bioon1, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1297775, encodeId=e3e0129e77537, content=<a href='/topic/show?id=33c1509e135' target=_blank style='color:#2F92EE;'>#心室重构#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50971, encryptionId=33c1509e135, topicName=心室重构)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80ca273, createdName=fanweitanzhen, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1465688, encodeId=dd7c14656881d, content=<a href='/topic/show?id=5f5f508933f' target=_blank style='color:#2F92EE;'>#心功能#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=50893, encryptionId=5f5f508933f, topicName=心功能)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6df96750284, createdName=caobinglei8081, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1609964, encodeId=3c8d160996471, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Fri Aug 30 10:03:00 CST 2019, time=2019-08-30, status=1, ipAttribution=)]
    2019-08-30 ms3994565386320060

    #Med#

    0

Baidu
map
Baidu
map
Baidu
map